Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus
Clinical trial NCT04582136 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04582136
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-04
- Primary completion
- 2025-04-21
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.